One‐week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of <i>Helicobacter pylori</i>‐related duodenal ulcer

Abstract

One-week RBC-based triple therapy is an effective treatment for H. pylori-related duodenal ulcers. The therapeutic effects are comparable to a 1-week course of proton pump inhibitor-based triple therapy.